Vycor Medical, Inc.
VYCO
$0.07
$0.00-1.71%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -18.86% | 3.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.86% | 3.51% | |||
| Cost of Revenue | 31.66% | -23.67% | |||
| Gross Profit | -25.78% | 8.81% | |||
| SG&A Expenses | -11.85% | 17.39% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.88% | 8.20% | |||
| Operating Income | -213.71% | -37.18% | |||
| Income Before Tax | -1,348.00% | -80.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,348.00% | -80.54% | |||
| Earnings from Discontinued Operations | -200.00% | 94.44% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,379.59% | -79.50% | |||
| EBIT | -213.71% | -37.18% | |||
| EBITDA | -142.50% | -27.49% | |||
| EPS Basic | 59.57% | -771.43% | |||
| Normalized Basic EPS | -1,300.00% | -80.00% | |||
| EPS Diluted | 59.57% | -883.33% | |||
| Normalized Diluted EPS | -1,300.00% | -75.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -13.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||